Malawi has made a substantial increase in its domestic HIV funding, rising from K178 million in 2024/25 to K4.5 billion in 2025/26, according to the Unicef Health Budget Brief. This represents a 2440 percent increase in just one year. Despite this significant boost, health experts argue that the allocation remains far below what is required to sustain the national HIV response. The country's annual HIV expenditure ranges between $350 million and $460 million, equivalent to roughly K600 billion to K800 billion.
The National Aids Commission (NAC) reports that Malawi's annual HIV expenditure ranges between $350 million and $460 million. National Aids Commission chief executive officer Dr. Beatrice Matanje noted that the increase in domestic financing does not match the support previously provided by development partners. She emphasized that there is a significant gap in funding, which affects not only treatment but also prevention and community-based services. The government allocation covers less than one percent of the K600 billion to K800 billion needed annually.
Health rights advocate Maziko Matemba welcomed the increase in domestic funding but stressed that it is just a starting point. He argued that Malawi remains heavily dependent on the Global Fund and bilateral partners, particularly for antiretroviral drugs and other essential commodities. Matemba, who is also chairperson of the Malawi Network of Aids Service Organisations, proposed that Malawi should increase domestic HIV-specific spending to cover 20 to 30 percent of core commodity costs within three years.
The funding gap threatens services that operate outside hospitals, including community outreach for treatment adherence and retention, condom distribution, HIV prevention among adolescent girls and young women, and community-led monitoring. Dr. Matanje urged the government to establish a domestically funded HIV essential-services package covering treatment continuity, high-impact prevention, and community delivery. She warned that protecting treatment alone is insufficient and that sustained investment in prevention, retention, and community delivery is essential.
Professor Victor Mwapasa of Kamuzu University of Health Sciences noted that the government had little choice but to increase domestic funding to prevent disruption of life-saving treatment. However, he warned that the funding gap means some services could still be squeezed. Mwapasa suggested that the government might have to prioritize treatment over prevention, including condom provision, if resources remain constrained. This could have long-term consequences, weakening efforts to prevent new infections and potentially increasing future treatment costs.
Parliamentary Committee on Health chairperson Anthony Masamba emphasized the need to protect paediatric HIV interventions and community programmes. He noted that Malawi continues to record new infections and that rural communities face challenges identifying children living with HIV and linking them to treatment. Masamba said his committee is pushing for about K600 million for community interventions and urged the government to sustain HIV funding and invest in community responses.
The financing squeeze comes as Malawi faces a broader contraction in external health assistance. US government funding to Malawi's health sector declined by an estimated 66 percent by July 1, 2025, while global external financing for HIV programmes in low- and middle-income countries fell by 18 percent in 2025 compared with 2024, according to UNAids. Malawi is among more than 50 countries that have reported planned increases in domestic public HIV budgets since 2025.
Key points
- Malawi's domestic HIV funding increased by 2440 percent to K4.5 billion in 2025/26.
- The country's annual HIV expenditure ranges between K600 billion and K800 billion.
- Malawi remains heavily dependent on external funding for HIV response, with a significant gap in domestic financing.
